As global tensions and economic uncertainties weigh on markets, the ASX 200 is expected to open slightly lower, reflecting broader concerns over potential geopolitical developments and their impact on investor sentiment. In this environment, dividend stocks can offer a measure of stability through regular income streams, making them an attractive option for investors seeking resilience amid market volatility. Top 10 Dividend Stocks In Australia Name Dividend Yield Dividend Rating Sugar Terminals (NSX:SUG) 8.37% ★★★★★☆ Nick Scali (ASX:NCK) 3.31% ★★★★★☆ New Hope (ASX:NHC) 9.87% ★★★★★☆ MFF Capital Investments (ASX:MFF) 3.74% ★★★★★☆ Lycopodium (ASX:LYL) 7.35% ★★★★★☆ Lindsay Australia (ASX:LAU) 7.05% ★★★★★☆ IPH (ASX:IPH) 7.66% ★★★★★☆ Fiducian Group (ASX:FID) 4.80% ★★★★★☆ Bisalloy Steel Group (ASX:BIS) 9.85% ★★★★★☆ Accent Group (ASX:AX1) 9.70% ★★★★★☆ Click here to see the full list of 29 stocks from our Top ASX Dividend Stocks screener. Let's uncover some gems from our specialized screener. Bisalloy Steel Group Simply Wall St Dividend Rating: ★★★★★☆ Overview: Bisalloy Steel Group Limited manufactures and sells quenched and tempered, high-tensile, and abrasion-resistant steel plates in Australia, Indonesia, Thailand, and internationally with a market cap of A$156.59 million. Operations: Bisalloy Steel Group Limited generates revenue through the production and distribution of high-performance steel plates, including quenched and tempered, high-tensile, and abrasion-resistant varieties across various international markets. Dividend Yield: 9.8% Bisalloy Steel Group offers a compelling dividend yield of 9.85%, placing it in the top 25% of Australian dividend payers. However, its dividends have been volatile and unreliable over the past decade, with significant annual drops. Despite this instability, recent earnings growth of 14% and sustainable payout ratios—81.2% from earnings and 66.6% from cash flows—suggest current dividends are covered. The stock trades at good value relative to peers and industry estimates, enhancing its appeal for income-focused investors seeking high yields amidst volatility concerns. Navigate through the intricacies of Bisalloy Steel Group with our comprehensive dividend report here. The valuation report we've compiled suggests that Bisalloy Steel Group's current price could be quite moderate.ASX:BIS Dividend History as at Jun 2025 Lycopodium Simply Wall St Dividend Rating: ★★★★★☆ Overview: Lycopodium Limited offers engineering and project delivery services across the resources, rail infrastructure, and industrial processes sectors in Australia, with a market cap of A$407.25 million. Story Continues Operations: Lycopodium Limited's revenue is primarily derived from its resources segment, which generated A$347.83 million, with additional contributions of A$10.84 million from process industries and A$10.14 million from rail infrastructure sectors. Dividend Yield: 7.4% Lycopodium's dividend yield of 7.35% ranks in the top 25% of Australian payers, yet its past decade has seen volatility and unreliability with annual drops over 20%. Despite this, dividends are well-covered by earnings (43.2%) and cash flows (80.8%). The stock is trading at a discount to its estimated fair value, offering potential value for investors. Recent board changes with Rob Radici's appointment may influence strategic direction amidst industry expertise in major projects. Click to explore a detailed breakdown of our findings in Lycopodium's dividend report. Insights from our recent valuation report point to the potential undervaluation of Lycopodium shares in the market.ASX:LYL Dividend History as at Jun 2025 Medibank Private Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Medibank Private Limited operates as a provider of private health insurance and health services in Australia, with a market capitalization of A$13.44 billion. Operations: Medibank Private Limited generates revenue primarily from its Health Insurance segment, which accounts for A$8.06 billion, and its Medibank Health segment, contributing A$447.10 million. Dividend Yield: 3.4% Medibank Private's dividend yield of 3.4% is below the top 25% in Australia and not well covered by earnings, with a high payout ratio of 96.7%. However, dividends have been stable and reliable over the past decade, supported by cash flows with an 82.6% cash payout ratio. Despite recent legal challenges related to a cybercrime event, Medibank trades at a discount to its estimated fair value, potentially offering value for investors seeking stability amidst growth prospects. Click here to discover the nuances of Medibank Private with our detailed analytical dividend report. According our valuation report, there's an indication that Medibank Private's share price might be on the expensive side.ASX:MPL Dividend History as at Jun 2025 Where To Now? Click through to start exploring the rest of the 26 Top ASX Dividend Stocks now. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Looking For Alternative Opportunities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BIS ASX:LYL and ASX:MPL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Dividend Stocks To Watch In June 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...